Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pulmonology

Recognizing Symptoms and Emergency Warning Signs

At a Glance

PVOD can cause worsening breathlessness, major oxygen drops during activity, and fluid in the lungs after some pulmonary hypertension medicines. Sudden severe breathing trouble, fainting, chest pain, confusion, or falling oxygen levels are emergency warning signs.

The symptoms of Pulmonary Venoocclusive Disease (PVOD) often mimic more common heart or lung conditions, which can make it difficult to recognize early on. However, as the disease progresses, the symptoms become more distinct, often characterized by a significant mismatch between how much effort you are putting in and how breathless you feel [1]. Understanding these patterns—and knowing which signs require immediate medical action—is essential for your safety.

Common Daily Symptoms

In the early stages, PVOD symptoms are often “nonspecific,” meaning they look like many other illnesses. You may simply feel more tired than usual or find that activities you once enjoyed are becoming difficult [2].

  • Progressive Shortness of Breath: This is the most common symptom, typically beginning only during exercise but eventually occurring even while resting [3].
  • Fatigue and Weakness: Because your heart must work harder to push blood through blocked veins, you may feel a deep, persistent exhaustion [2].
  • Dizziness and Fainting: Known medically as syncope, fainting or feeling lightheaded occurs because the overworked right heart is unable to increase cardiac output enough during physical exertion to meet the body’s demands [1][4].
  • Chest Pain and Palpitations: You may feel discomfort in your chest or a racing heart rate when you try to be active [1].
  • Dry Cough: A persistent cough can sometimes be an early indicator of changes within the lung’s small vessels [2].

Profound Oxygen Drops (Hypoxemia)

One of the hallmark features of PVOD is a rapid and severe drop in blood oxygen levels during physical activity, a condition called exertional hypoxemia [5].

While many lung diseases cause some drop in oxygen, the desaturation in PVOD is often much more profound [6]. This happens because the narrowed veins and overworked capillaries cannot efficiently transfer oxygen into the bloodstream when the body’s demand increases during movement [7]. During a supervised six-minute walk test, many patients with PVOD will see a significant drop in their oxygen saturation (SpO2) [5][6]. You may notice cyanosis, a bluish or grayish tint to your lips, skin, or fingernails, during these episodes [8]. Your PH team will set individualized oxygen targets and flow rates for you based on these tests. Do not change your oxygen flow based on one home reading.

Medication-Induced Pulmonary Edema

A unique and critical risk in PVOD is the development of pulmonary edema (fluid in the lungs) after starting certain medications. Most drugs used for “typical” pulmonary hypertension (Group 1 PAH) are vasodilators, which work by opening up the arteries.

In PVOD, opening the arteries allows more blood to rush into the lungs, but because the veins (the “exit pipes”) are blocked, that blood has nowhere to go [9]. The pressure causes fluid to leak out of the vessels and into the air sacs of the lungs [10]. This is a medical emergency and often serves as a primary clue that a patient has PVOD rather than standard PAH [11].

Watch for these signs within hours or days of starting or increasing a new PH medication:

  • A sudden, sharp increase in shortness of breath.
  • A new or worsening cough, sometimes producing frothy or pink-tinged phlegm.
  • An inability to lie flat without feeling like you are suffocating.
  • Rapidly falling oxygen levels that do not recover with rest [12][11].

Do not start, stop, or change PAH medication independently. If you experience these signs, contact your PH center immediately.

When to Seek Emergency Care

Because PVOD can progress quickly and reacts poorly to standard treatments, you must be vigilant about “red flag” symptoms. Call emergency services or go to the nearest emergency room immediately if you experience any of the following:

  1. Sudden Severe Breathlessness: If you are gasping for air while sitting still or if your breathing worsens rapidly after taking a new medication [11].
  2. Fainting or Collapse: Any loss of consciousness is a sign that your heart and lungs are struggling to support your brain [4].
  3. Chest Pain: Intense or crushing chest pain, especially if it radiates to your arms, neck, or jaw [1].
  4. Signs of Right Heart Failure: Rapid swelling in your ankles, legs, or abdomen, or a sudden decrease in how much you urinate [4][13].
  5. Confusion or Extreme Dizziness: This can indicate that your blood pressure has dropped too low or your oxygen levels are critically shallow [11].

Do not delay emergency care for fear that standard treatments will make PVOD worse. Instead, carry a PVOD/suspected-PVOD letter, medication list, and specialist contact information. Ensure the emergency medical team knows you have suspected PVOD so they can consult your PH center immediately [9][14]. Acute treatments, including oxygen, diuresis, and circulatory support, can be lifesaving when individualized.

Common questions in this guide

What symptoms can pulmonary venoocclusive disease cause?
PVOD often starts with worsening shortness of breath during activity, fatigue, weakness, dry cough, chest discomfort, or a racing heartbeat. As it progresses, breathlessness may occur at rest, and dizziness or fainting can develop because the heart cannot increase blood flow enough during exertion.
Why can oxygen levels fall sharply during exercise with PVOD?
In PVOD, narrowed or blocked small veins and capillaries in the lungs limit how well oxygen moves into the blood when the body needs more during activity. A supervised six-minute walk test can show this drop and help the pulmonary hypertension team set a personalized oxygen target.
Could a pulmonary hypertension medicine cause pulmonary edema in PVOD?
Yes. Some medicines that widen the lung arteries can send more blood into the lungs while the narrowed veins cannot let it out, allowing fluid to build up in the air sacs. Sudden worsening breathlessness, a new or worsening cough with frothy or pink-tinged mucus, difficulty lying flat, or oxygen levels that keep falling require immediate medical attention; do not change the medicine on your own.
When should I seek emergency care for PVOD?
Call emergency services or go to an emergency department for severe breathlessness at rest, fainting or collapse, intense chest pain, rapidly worsening swelling of the legs or abdomen, much less urine, confusion, or extreme dizziness. Tell the emergency team that you have suspected or diagnosed PVOD and ask them to contact your pulmonary hypertension center.
How should I use oxygen at home if I have PVOD?
Your pulmonary hypertension team should set your oxygen target and flow rate using your symptoms, home readings, and supervised testing such as a six-minute walk. Do not change the flow based on one home reading; ask your team exactly when to use oxygen at home or while walking.
What should I bring to the hospital if PVOD symptoms suddenly worsen?
Carry a letter noting PVOD or suspected PVOD, an up-to-date medication list, and your specialist’s contact information. Sharing these details promptly helps the emergency team consult your pulmonary hypertension center and choose individualized support.

Get notified when new evidence is published on Pulmonary venoocclusive disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Pulmonary veno-occlusive disease in childhood-a rare disease not to be missed.

    Pfluger M, Humpl T

    Cardiovascular diagnosis and therapy 2021; (11(4)):1070-1079 doi:10.21037/cdt-20-320.

    PMID: 34527533
  2. 2

    Pulmonary veno-occlusive disease: An important consideration in patients with pulmonary hypertension.

    Balko R, Edriss H, Nugent K, Test V

    Respiratory medicine 2017; (132()):203-209 doi:10.1016/j.rmed.2017.10.015.

    PMID: 29229098
  3. 3

    Pulmonary Veno-occlusive Disease in a Military Pilot: Case Report and Mini-review.

    Radchenko G, Botsiuk Y, Dyadyk O, et al.

    Current cardiology reviews 2026; (22(5)):e1573403X412872 doi:10.2174/011573403X412872251107111309.

    PMID: 41588905
  4. 4

    Pulmonary hypertension secondary to pulmonary veno-occlusive disease complicated by right heart failure, hypotension and acute kidney injury.

    Golzy N, Fernandes S, Sharim J, et al.

    Respiratory medicine case reports 2017; (20()):10-13 doi:10.1016/j.rmcr.2016.09.005.

    PMID: 27872804
  5. 5

    Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.

    Ogawa A, Takahashi Y, Matsubara H

    Journal of cardiology 2018; (72(3)):255-260 doi:10.1016/j.jjcc.2018.02.009.

    PMID: 29548663
  6. 6

    A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.

    Kyono M, Okamoto M, Sakamoto S, et al.

    Modern rheumatology case reports 2020; (4(2)):248-252 doi:10.1080/24725625.2020.1755516.

    PMID: 33086997
  7. 7

    Pulmonary capillary haemangiomatosis: a distinct entity?

    Weatherald J, Dorfmüller P, Perros F, et al.

    European respiratory review : an official journal of the European Respiratory Society 2020; (29(156)) doi:10.1183/16000617.0168-2019.

    PMID: 32461209
  8. 8

    Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.

    Hamada T, Takahashi H, Nakagawa M, et al.

    Case reports in oncology 2023; (16(1)):338-346 doi:10.1159/000530265.

    PMID: 37384208
  9. 9

    Pulmonary veno-occlusive disease: illustrative cases and literature review.

    Lechartier B, Boucly A, Solinas S, et al.

    European respiratory review : an official journal of the European Respiratory Society 2024; (33(171)) doi:10.1183/16000617.0156-2023.

    PMID: 38232988
  10. 10

    Acute venodilation properties of low-dose intravenous nitroglycerine in pulmonary veno-occlusive disease: a case report.

    Maruyama H, Sakai S, Suzuki S

    European heart journal. Case reports 2023; (7(8)):ytad365 doi:10.1093/ehjcr/ytad365.

    PMID: 37575546
  11. 11

    A Challenging Case of Genetically and Histologically Diagnosed Pulmonary Veno-Occlusive Disease with Extracorporeal Life Support and Redo Lung Transplantation.

    Laimoud M, Alanazi Z, Alahmadi F, Aldalaan A

    Case reports in cardiology 2023; (2023()):4846338 doi:10.1155/2023/4846338.

    PMID: 37649985
  12. 12

    Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .

    Daraban AM, Enache R, Predescu L, et al.

    Romanian journal of internal medicine = Revue roumaine de medecine interne 2015; (53(2)):175-83 doi:10.1515/rjim-2015-0024.

    PMID: 26402988
  13. 13

    Pulmonary Veno-Occlusive Disease: A Focused Clinicopathologic Series.

    Sedhai YR, Kattih Z, Thomas CA, et al.

    Pulmonary circulation 2026; (16(3)):e70365 doi:10.1002/pul2.70365.

    PMID: 42516692
  14. 14

    Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.

    Certain MC, Chaumais MC, Jaïs X, et al.

    Chest 2021; (159(3)):1197-1207 doi:10.1016/j.chest.2020.09.238.

    PMID: 32979348

This page is for informational purposes only and does not constitute medical advice. It explains PVOD warning signs; follow your pulmonary hypertension team’s personalized oxygen and medication plan and seek emergency care for severe symptoms.